Join the Ischemic Stroke group to help and get support from people like you.
Ischemic Stroke News (Page 10)
Related terms: Cerebrovascular Accident (CVA), Stroke, CVA, Cerebrovascular Accident, Stroke, ischemic
Adverse Pregnancy Outcomes Increase Stroke Risk at an Earlier Age
TUESDAY, May 30, 2023 – Women who experience an adverse pregnancy outcome (APO) have a higher risk of having a stroke in their lifetime, and at a younger age, according to a study published online...
Higher Poststroke Glucose Levels Tied to Faster Cognitive Decline
FRIDAY, May 26, 2023 – Higher poststroke glucose levels are associated with faster subsequent global cognitive decline, according to research published online May 17 in JAMA Network Open. Deborah A....
Pregnancy Complications Linked to Higher Stroke Risk for Women
MONDAY, May 22, 2023 – Women who’ve had certain pregnancy complications have significantly higher odds for a stroke than women with uncomplicated pregnancies, new research shows. Moreover, these s...
AHA News: Stroke Rehab Improves Recovery. So Why Aren't Hispanic Survivors Getting Enough of It?
MONDAY, May 22, 2023 (American Heart Association News) – Joe Granados was slumped in a chair when his wife – alerted by their children – came to check on him. He didn't seem like himself. Alba Pat...
Brilinta Approved in the US to Reduce the Risk of Stroke in Patients with an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
6 November 2020 – AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability and death worldwide, in patients with acute ischemic str...
FDA Approves Praluent (alirocumab) to Prevent Heart Attack, Stroke and Unstable Angina Requiring Hospitalization
PARIS and TARRYTOWN, NY – April 26, 2019 – The U.S. Food and Drug Administration (FDA) has approved Praluent (alirocumab) to reduce the risk of heart attack, stroke, and unstable angina requiring hos...
FDA Medwatch Alert: Plavix (clopidogrel): Drug Safety Communication - Long-term Treatment Does Not Change Risk of Death
ISSUE: An FDA review has determined that long-term use of the blood-thinning drug Plavix (clopidogrel) does not increase or decrease overall risk of death in patients with, or at risk for, heart...
Ask a question
To post your own question to this support group, sign in or create an account.